|
|
|
|
LEADER |
01983nam a22003855i 4500 |
001 |
000277109 |
005 |
20211026182917.0 |
007 |
cr nn 008mamaa |
008 |
100301s2007 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387740393
|
024 |
7 |
|
|a 10.1007/978-0-387-74039-3
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Breast Cancer Chemosensitivity /
|c edited by Dihua Yu, Mien-Chie Hung.
|
250 |
|
|
|a 1st ed. 2007.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2007.
|
300 |
|
|
|a XIII, 175 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 608
|
505 |
0 |
|
|a Overview of Resistance to Systemic Therapy in Patients with Breast Cancer -- Roles of Multidrug Resistance Genes in Breast Cancer Chemoresistance -- Therapy-Induced Apoptosis in Primary Tumors -- Cell Cycle Deregulation in Breast Cancer: Insurmountable Chemoresistance or Achilles’ Heel? -- p53, BRCA1 and Breast Cancer Chemoresistance -- Integrin-Mediated Adhesion: Tipping the Balance between Chemosensitivity and Chemoresistance -- Insulin-Like Growth Factors and Breast Cancer Therapy -- EGF Receptor in Breast Cancer Chemoresistance -- Molecular Mechanisms of ErbB2-Mediated Breast Cancer Chemoresistance -- Estrogen Receptors in Resistance to Hormone Therapy -- Novel Approaches for Chemosensitization of Breast Cancer Cells: The E1A Story.
|
650 |
|
0 |
|a Oncology .
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Biochemistry.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Cell biology.
|
650 |
1 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Biochemistry, general.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Cell Biology.
|
700 |
1 |
|
|a Yu, Dihua.
|e editor.
|
700 |
1 |
|
|a Hung, Mien-Chie.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|